Tech Company Financing Transactions
Rx3 Pharmaceuticals Funding Round
Rx3 Pharmaceuticals, based in San Diego, secured $800 thousand in funding from Tech Coast Angels.
Transaction Overview
Company Name
Announced On
9/30/2006
Transaction Type
Venture Equity
Amount
$800,000
Round
Undisclosed
Investors
Tech Coast Angels (Julia Brown)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
6310 Nancy Ridge Drive 105
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Not Recorded
Overview
Rx3 has built an unique set of technologies that can rapidly discover novel classes of antimicrobial agents and advance these leads into clinical candidates.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Stein
Chief Financial Officer
John Schmid
Chief Medical Officer
Philippe Prokocimer
Chief Operating Officer
Kenneth Bartizal
Chief Scientific Officer
John Finn
Browse more venture capital transactions:
Prev: 9/30/2006: Cempra venture capital transaction
Next: 9/30/2006: SecureWorks venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs